SCHEMBL2728060

SCHEMBL2728060

C[C@H](NC(=O)O)C(O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.53
LMNA P02545 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HPGD P15428 1/20 0.50
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
ACP3 P15309 1/20 0.48
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22836032 0.84 HTT (0.56) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL3861412 0.84 HTT (0.56) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL3861418 0.84 HTT (0.56) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL10521250 0.82 MAPT (0.51) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL8790902 0.82 MEN1 (0.60) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL2458450 0.81 HTT (0.53) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL2458448 0.81 HTT (0.53) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL3018937 0.79 ACP3 (0.45) LMNAALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL3018939 0.79 ACP3 (0.45) LMNAALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL16783370 0.79 HTT (0.55) HTTLMNAL3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632908-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS Merck Canada Inc. (CA) 2013-09-04 EP disclosed
WO-2012055034-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2012-05-03 WO disclosed